10. For dose-escalation cohort, patient has at least 1 measurable disease as defined by RECIST criteria (Version 1.1). For dose-expansion cohort, patient has at least 1 measurable disease as defined by RECIST criteria (Version 1.1) with a lesion larger than 1.5 cm that can be biopsied by core needle biopsy.